Exploration of predictive biomarkers in checkpoint inhibitor, nivolumab, for recurrent esophageal squamous cell carcinoma after standard therapy
Not Applicable
- Conditions
- Esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000042908
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
None.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method